After axillary lymphatic metastasis of breast cancer, the five-year survival rate varies from 30% to 90%, which is related to the stage. Breast cancer is a common malignant tumor in women, and the occurrence of the disease is related to heredity, hormone level, gene mutation and other factors. With the development of the disease, it is often accompanied by axillary lymph node metastasis, which can be stage II-IV in TNM staging, and the prognosis of different stages varies greatly after surgery, radiotherapy and other treatments. For stage II, the five-year survival rate is about 90%; for stage III, about 75%; and for stage IV, about 30%. In short, the earlier the stage, the higher the clinical cure rate. Therefore, in order to get a better prognosis, one should cooperate with doctors for treatment in time after diagnosis. After discovering breast cancer, one should actively carry out treatment under the guidance of doctors, and at the same time maintain a good mindset and improve immunity through exercise to resist the disease.